Compass Therapeutics Inc. (CMPX) earnings · $367.4M cap
These earnings events as JSON? API free 100/dayCompass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
This CMPX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CMPX revenue for 2025-12-31 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CMPX currently screens at market cap $367.4M.
When the next CMPX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CMPX research stays on the stock page; the tape stays on the quote page.
CMPX earnings FAQ
What is CMPX's latest net income?
Latest cached Compass Therapeutics Inc. (CMPX) net income was -$66.5M. Statements: https://lician.com/financials/cmpx
What is CMPX's latest basic EPS?
Latest cached Compass Therapeutics Inc. (CMPX) basic EPS for Dec 31, 2025 was -$0.42.
What period does the latest CMPX earnings print cover?
The latest cached Compass Therapeutics Inc. (CMPX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are CMPX earnings listed?
Cached earnings facts for Compass Therapeutics Inc. (CMPX) are listed at https://lician.com/earnings/cmpx. Statements: https://lician.com/financials/cmpx
Not investment advice.